PUBLIC PRESS RELEASE 10 NOVEMBER[removed]Pres s Releas e

First Page		Document Content
Date: 2012-06-19 08:28:54 Ammine complexes Lipoplatin Carboplatin Cisplatin Oxaliplatin Gemcitabine Liposome Glioma Chemotherapy regimens Chemistry Medicine Alkylating antineoplastic agents		PUBLIC PRESS RELEASE 10 NOVEMBER[removed]Pres s Releas e Add to Reading List Source URL: regulon.org Download Document from Source Website File Size: 1,38 MB Share Document on Facebook

	Vergleich der Zytotoxizität von ChAPt-11 und Cisplatin an einer TumorzelllinieZellwachstum (% zur Kontrolle) DocID: 1vkVQ - View Document
	Effect of Pemetrexed Alone or Pemetrexed-Cisplatin Regimens on the Liver and Renal Parameters in Adult Cancer Patients DocID: 1uZLR - View Document
	Phase 1b Trial of Tarextumab (OMP 59R5) (anti-Notch 2/3 antibody) in Combination with Etoposide and Cisplatin (EP) in Patients (pts) with Untreated Extensive-Stage Small-Cell Lung Cancer (ED-SCLC): PINNACLE Study M Cathe DocID: 1t2mY - View Document
	DBCGBehandling med Cisplatin v. metastaserende mamma cancer DANISH BREAST CANCER COOPERATIVE GROUP DocID: 1sFBW - View Document
	TACTIC: Phase 2 trial of panitumumab, cisplatin and gemcitabine in biliary tract cancer The TACTIC trial is helping researchers answer an important health question. It is providing evidence on whether panitumumab (Vectib DocID: 1sxxH - View Document